Wanebo H, Coburn M, Teates D, Cole B
Division of Surgical Oncology, Brown University, Providence, Rhode Island 02908, USA.
Ann Surg. 1998 Jun;227(6):912-21. doi: 10.1097/00000658-199806000-00015.
The extent of primary thyroidectomy for differentiated thyroid cancer is controversial. There are strong proponents for total thyroidectomy based on its presumed and theoretical disease control benefits. In contrast, there are equally strong advocates of less aggressive thyroidectomy with its lower hazard of parathyroid and recurrent nerve injury. The authors have addressed whether total thyroidectomy has a survival benefit justifying its use in patients with high-risk primary cancer. The major risk factors include age and the following the pathologic determinants follicular histology, vascular invasion, and extracapsular extension.
The clinical pathologic, therapeutic, prognostic, and outcome data were reviewed in 347 patients with well-differentiated thyroid cancer. Seventy-five percent were women, 216 patients were in the younger age group (low-risk) (21-50 years), 103 were in the intermediate-risk group (51-70 years), and 28 were in the high-risk group (>70 years). Included in the high-risk pathologic category were 158 patients who had follicular histology (55), extracapsular extension (107), or vascular invasion (119). Total thyroidectomy was performed in 56 patients, near or subtotal thyroidectomy in 47 patients and lobectomy in 55 patients. The 10-year disease specific survival in the overall patient group was 82% in patients with total thyroidectomy, 78% in patients with subtotal thyroidectomy, and 89% in patients with lobectomy (p = 0.30). There was no significant survival difference according to extent of thyroidectomy in the intermediate or high-risk groups either by age or in patients who had high-risk pathologic feature.
Total thyroidectomy in high-risk patients with differentiated thyroid cancer (containing follicular histology, vascular invasion, or extracapsular extension) showed no benefit over partial thyroidectomy. This suggests that the general use of total thyroidectomy is not indicated, except in highly selected patients.
分化型甲状腺癌初次甲状腺切除术的范围存在争议。基于其假定的和理论上的疾病控制益处,有很多人强烈支持全甲状腺切除术。相比之下,也有同样多的人主张采取侵袭性较小的甲状腺切除术,因为其甲状旁腺和喉返神经损伤风险较低。作者探讨了全甲状腺切除术对高危原发性癌患者是否具有生存益处,是否值得应用。主要风险因素包括年龄以及以下病理决定因素:滤泡组织学、血管侵犯和包膜外侵犯。
回顾性分析347例分化型甲状腺癌患者的临床病理、治疗、预后及转归数据。75%为女性,216例患者为较年轻年龄组(低危组)(21 - 50岁),103例为中危组(51 - 70岁),28例为高危组(>70岁)。高危病理类型包括158例具有滤泡组织学(55例)、包膜外侵犯(107例)或血管侵犯(119例)的患者。56例行全甲状腺切除术,47例行近全或次全甲状腺切除术,55例行甲状腺叶切除术。总体患者组中,全甲状腺切除术患者的10年疾病特异性生存率为82%,次全甲状腺切除术患者为78%,甲状腺叶切除术患者为89%(p = 0.30)。在中危或高危组中,无论按年龄还是具有高危病理特征的患者,甲状腺切除术范围不同,生存率均无显著差异。
高危分化型甲状腺癌(包含滤泡组织学、血管侵犯或包膜外侵犯)患者行全甲状腺切除术相较于部分甲状腺切除术并无益处。这表明,除了经过严格挑选的患者外,一般不建议常规使用全甲状腺切除术。